(Q41737190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Etienne A Thévenot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sylvie Job

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Céline Narjoz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Philippe Beaune

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christian Funck-Brentano

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

11

France Mentré

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Natacha Lenuzza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xavier Duval

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Grégory Nicolas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Orianne Videau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Laurent Becquemont

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Loubna Alavoine

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Philippe Arnaud

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marcel Delaforge

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Henri Bénech

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

3 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Drug Metabolism and Pharmacokinetics

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

125-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25465228%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13318-014-0239-0

24 February 2020

exact match

0 references

cites work

In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age.

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Mechanisms, manifestations, and management of digoxin toxicity in the modern era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Dose dependent pharmacokinetics of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Prediction of shrinkage of individual parameters using the bayesian information matrix in non-linear mixed effect models with evaluation in pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Influence of urine pH and urinary flow on the renal excretion of memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Two cases of fulminant hepatitis during a curative treatment with an artesunate-amodiaquine combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Functions of OATP1A and 1B transporters in vivo: insights from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Variability in drug metabolizing enzyme activity in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potentia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Population pharmacokinetic study of memantine: effects of clinical and genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Summary of information on human CYP enzymes: human P450 metabolism data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

A comprehensive assessment of repaglinide metabolic pathways: impact of choice of in vitro system and relative enzyme contribution to in vitro clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Applications of CYP450 testing in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Clinical relevance of genetic polymorphisms in the human CYP2C9 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Can a cocktail designed for phenotyping pharmacokinetics and metabolism enzymes in human be used efficiently in rat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Biochemical and analytical development of the CIME cocktail for drug fate assessment in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Meglitinide analogues: a review of clinical data focused on recent trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pharmacokinetics of tolbutamide in ethnic Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Cytochrome P450 2C9 phenotyping using low-dose tolbutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Serum metabolite/caffeine ratios as a test for liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pharmacokinetic and Pharmacodynamic Interactions of Oral Midazolam with Ketoconazole, Fluoxetine, Fluvoxamine, and Nefazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Lack of citalopram effect on oral digoxin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Measurement of CYP1A2 activity: a focus on caffeine as a probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-014-0239-0

In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers

1 reference

12 December 2020

Omeprazole-associated digoxin toxicity

1 reference

12 December 2020

In vivo effect of clarithromycin on multiple cytochrome P450s

1 reference

12 December 2020

Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics

1 reference

12 December 2020

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes

1 reference

12 December 2020

In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery

1 reference

12 December 2020

Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma

1 reference

12 December 2020

Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice

1 reference

12 December 2020

Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.

1 reference

12 December 2020

A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening

1 reference

12 December 2020

The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1

1 reference

12 December 2020

Unexpected drug-drug interactions in human immunodeficiency virus (HIV) therapy: induction of UGT1A1 and bile efflux transporters by Efavirenz

1 reference

12 December 2020